Abbott Molecular distribution of ELITechGroup products will expand distribution channels
Puteaux, France -- ELITechGroup today announced a distribution agreement with Abbott Molecular, Inc. for U.S. distribution of molecular diagnostic reagents. The reagents included in the agreement are focused on monitoring virus activity in patients that have undergone organ or hematopoietic stem cell transplantation. Other products included in the agreement will focus on the expanding need to test for additional sexually transmitted infections beyond Chlamydia and Gonorrhea. The agreement will provide a broader based distribution of ELITechGroup MGB Alert Analyte Specific Reagents. It is anticipated that the ELITechGroup products will be available from Abbott Molecular in early 2017.